A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant gain of 18.31% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 0.82%. Over the past 30 days, the price of ABT has fallen by 5.49%. And in the last five days, it has surged by 0.18%.
The current stock price for Abbott Laboratories (ABT) is $131.25. The stock experienced a significant increase during the last trading session, reaching $159.0 after opening at $131.25. It dipped to a low of $122.0 before ultimately closing at $130.27.
Abbott Laboratories’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $141.23 on 03/04/25, and the lowest price during that time was $110.33, recorded on 08/20/24.
52-week price history of ABT Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Abbott Laboratories’s current trading price is -7.07% away from its 52-week high, while its distance from the 52-week low is 18.96%. The stock’s price range for this period has been between $110.33 and $141.23. The Healthcare sector company’s shares saw a trading volume of about 4.67 million for the day, which was lower than the average daily volume of 6.62 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Abbott Laboratories (ABT) has experienced a quarterly decline of -3.17% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 228.44B and boasts a workforce of 114000 employees.
Expert Opinions: Analysts’ Ratings for Abbott Laboratories
As of right now, 14 analysts are rating Abbott Laboratories as a BUY, 6 of the polled analysts branded the stock as an OVERWEIGHT, 7 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 131.17, with a change in price of +4.64. Similarly, Abbott Laboratories recorded 6,873,591 in trading volume during the last 100 days, posting a change of +3.66%.
ABT’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for ABT stands at 0.27. Similarly, the long-term debt-to-equity ratio is also 0.26.
ABT Stock Stochastic Average
As of today, the raw stochastic average of Abbott Laboratories over the past 50 days is 59.51%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 69.81%. Additionally, the Stochastic %K and %D values for the company were 69.50% and 67.36%, respectively, over the past 20 days.
